BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Q, Fan S, Chang Y, Liu X, Li W, Ma Q, Li Y, Wang Y, Zhang L, Zhang M. Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III-IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus. Cancer Manag Res 2019;11:3555-64. [PMID: 31118779 DOI: 10.2147/CMAR.S191929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun Z, Wan W, Zhang X, Zhang L, Li X, Li L, Wang X, Nan F, Yu H, Chang Y, Yan J, Li Z, Cui F, Ge J, XiaXu YD, Xu X, Fu X, Zhang M. The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphoma. J Cancer Res Clin Oncol 2022. [PMID: 35857124 DOI: 10.1007/s00432-022-04203-x] [Reference Citation Analysis]
2 Hue SS, Ng SB, Wang S, Tan SY. Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders. Cancers (Basel) 2022;14:2483. [PMID: 35626087 DOI: 10.3390/cancers14102483] [Reference Citation Analysis]
3 Wu W, Ren K, Li N, Luo Q, Xu C, Zou L. Evaluation of different staging systems and prognostic analysis of nasal-type extranodal NK/T-cell lymphoma based on consistent LVDP chemotherapy regimen. Transl Oncol 2022;21:101437. [PMID: 35489119 DOI: 10.1016/j.tranon.2022.101437] [Reference Citation Analysis]
4 Mallal P, Ammanuel B, White R, Kennedy C, Cheah CY. Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab. Clin Case Rep 2021;9:e04194. [PMID: 34026185 DOI: 10.1002/ccr3.4194] [Reference Citation Analysis]
5 Fu XR, Wan WJ, Sun ZC, Zhang XD, Nan FF, Ge JR, Xia YQ, Zhang MZ. [Expression of CD7 and its correlation with prognosis in patients with NK/T-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2020;41:921-6. [PMID: 33333695 DOI: 10.3760/cma.j.issn.0253-2727.2020.11.007] [Reference Citation Analysis]
6 Wang X, Hu J, Dong M, Ding M, Zhu L, Wu J, Sun Z, Li X, Zhang L, Li L, Wang X, Fu X, Wang G, Chen Q, Zhang M, Zhang X. DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients. Clin Transl Sci 2021;14:405-11. [PMID: 33045134 DOI: 10.1111/cts.12893] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]